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DNA Binding Hairpin Polyamides
with Antifungal Activity
cal 8-ring hairpin has a MW of 1222) use a side-by side
pairing scheme in the minor groove [15], and a broad-
ened heterocycle amino acid repertoire to bind to spe-
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and Eldon E. Baird2,4,* cific predetermined DNA sequences according to a ring-
pair:base-pair code [16–18]. A variety of templates have1Department of Microbial Genomics
2 Department of Synthetic Chemistry been developed to use the pairing code for recognition
of sites from 6–16 base pairs [19, 20]. One useful motif3 Department of Pharmacology
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acids, which bind to discrete sites with subnanomolar
affinities [21]. These compounds have been shown to
modulate transcription in vitro and viral replication inSummary
human cells [22, 23]. However, uptake of hairpin com-
pounds may currently be limited to certain cell types [24].Eight-ring hairpin polyamides containing N-methyl-
imidazole (Im) and N-methylpyrrole (Py) amino acids The question that we address here is to determine if
the hairpin compounds, with their greater potential forhave been shown to bind with subnanomolar affinity
to discrete DNA sites and to modulate a variety of rational sequence targeting, can be used against antiin-
fective targets in microorganisms. We report chemicalDNA-dependent biological processes. We show here
that addition of a second positive charge at the principles for conferring antifungal activity on hairpin
polyamides and begin to assess mechanism-of-action.C terminus of an 8-ring hairpin polyamide confers ac-
tivity against a number of clinically relevant fungal Our data indicate that activity is mediated by a reversible
interaction with chromosomal DNA that does not inducestrains in vitro, and activity against Candida albicans
in a mouse model. Control experiments indicate that DNA damage and may interfere with transcription of a
discrete set of genes.the observed antifungal activity results from a DNA
binding mechanism-of-action that does not involve
DNA damage or disruption of chromosomal integrity. Results and Discussion
Hairpin activity is shown to be proportional to yeast
DNA content (ploidy). Transcriptional interference is Chemistry
proposed as the likely explanation for fungal cytotox- All compounds were synthesized by stepwise Boc-
icity. Experiments with sensitized yeast strains indi- chemistry solid phase methods [25] and isolated as the
cate the potential for discrete sites of action rather acetate salts using 0.1% acetic acid in the HPLC mobile
than global effects. phase. Hairpins containing a single dimethylaminopro-
pylamino (Dp) tail were synthesized on Boc--PAM-
Introduction resin (  -alanine); hairpins with two Dp tails were
prepared on Boc-D-Asp(OBzl)-PAM resin. The Dp tail(s)
The natural product distamycin (Py-Py-Py) was first was introduced during the final aminolysis/resin cleav-
discovered by Arcamone and coworkers over 40 years age step, which substitutes the PAM carboxylic ester as
ago [1, 2]. This crescent-shaped synthetic compound well as the -carboxybenzyl ester. In this way, identical
containing three pyrrole amino acids was found to bind solid phase cycles utilizing two different starting resins
DNA in the minor groove and to inhibit DNA-dependent produced the compounds shown in Figure 1.
processes, including transcription [3]. Distamycin has
modest antibacterial [4], antimalarial [5], antifungal [6],
DNA Binding Effectsand antiviral activities [7], but is limited to topical use
Compound 1 ImPyPyPy--PyPyPyPy--Dp ( because of toxicity [8]. Recent efforts to bring an opti-
-aminobutyric acid) and Compound 2 ImPyPyPy--Pymized distamycin to the clinic have focused on small
PyPyPy-Asp-(Dp)-Dp are predicted to bind to a 5-synthetic analogs for use as antibacterial [9, 10], antifun-
WWGWWWW-3 binding site (W  A or T); Compoundgal [11], or antimalarial therapeutics [12]. These analogs
3, ImPyPyPy--ImPyPyPy--Dp, and compound 4, Im-generally have been optimized for pathogen activity as
PyPyPy--ImPyPyPy-Asp-(Dp)-Dp are predicted to bindwell as pharmacological properties, with DNA binding
to a 5-WWGWWCW-3 target site. DNase I footprintingaffinity and specificity not providing a major driving force
revealed that Hairpin 2, which contains 2 Dp residuesin compound design or selection.
at the C terminus, has an approximate 10-fold reductionSeparate work has focused on controlling the DNA
in DNA binding affinity for a 5-ATGTATT-3 match sitebinding sequence specificity of minor groove binding
relative to the singly substituted parent compound (Fig-ligands [13–14]. For example, larger analogs such as
ure 1). Compound 4 also has a 10-fold reduction inhairpin polyamides (distamycin has a MW of 518, a typi-
binding affinity relative to compound 3 for its 5-ATG
TACT-3 match site. Affinity at the 5-ATGTATT-3 (mis-4 Present address: Oakwood Products, Inc., West Columbia, SC
match base pair underlined) single base pair mismatch29172
*Correspondence: nmarini@att.net; ebaird@oakwoodchemical.com site is also reduced by 10-fold for compound 4 relative
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Figure 1. Structures and Schematic Models of Eight-Ring Hairpin Polyamides
ImPyPyPy--PyPyPyPy--Dp (1), ImPyPyPy--PyPyPyPy-(Dp)Asp-Dp (2), ImPyPyPy--ImPyPyPy--Dp (3), and ImPyPyPy--ImPyPyPy-
(Dp)Asp-Dp (4). Filled and open circles represent imidazole (Im) and pyrrole (Py) polyamide rings, respectively, targeted to their match DNA
base pairs. A diamond represents the C-terminal -amino acid (-carboxamido Asp or -alanine) and a plus sign represents the charged
dimethylaminopropylamido (Dp) tail (2-Dp for Asp, 1-Dp for -alanine). -Aminobutyric acid () is depicted by a curved line. Equilibrium
association constants (Ka) for each polyamide binding to the indicated match (indicated in bold) and mismatch sites were determined by
DNase I footprinting. Specificity was determined by the ratio of the resulting binding constants ([Ka match site]/[Ka mismatch site]). In vitro
susceptibility testing (MIC) for Saccharomyces cerevisiae was conducted by the NCCLS broth microplate assay in 100 l volumes in 96-well
plates in YPD media. It should be noted that the mismatch site Ka reported for compound 2 ( 1  108 M	1) represents a lower limit, as the
DNase titration was only carried up to 10 nM concentration and was not repeated.
to compound 3; thus, specificity is relatively unchanged observed for compounds that differ from -Dp to Gly-
Dp at the C terminus, addition of the second Dp-carbox-(reduced by about a factor of 2), 30-fold for compound
3 and 19-fold for compound 4. For compound 2, footprint amide residue results in a surprisingly small difference in
the DNA binding properties of these compounds. Thesetitration experiments were only run at concentrations 
10 nM; thus, we can only report a lower limit for specific- results indicate that correct placement of the terminal
amide in the minor groove may be more significant fority of compound 2. For the design of DNA binding hair-
pins, this work adds to the knowledge of acceptable tail binding specificity (avoiding reverse orientation) than
steric effects on the tail.groups that can be accommodated at the C termini of
hairpin polyamides. To summarize, Py-Dp and Py--Dp
[26], and the Py-Asp(Dp)-Dp termini reported here, pro-
vide hairpins with comparable DNA binding specificity In Vitro Activity of Hairpin Polyamides
The singly charged parent compounds 1 and compound(at least for sites adjacent to an A or T base pair) [27], but
Py-Gly-Dp [26] and Py--Dp (unpublished data) show 3 show no antifungal activity, even at concentrations
greater than 64 g/ml (50 M) (the solubility of the 8-ringgreatly reduced binding specificity, perhaps due to an
increased preference for binding in the 5-3C-N reverse hairpins in water is approximately 100 M). Addition of
the second Dp residue to provide the doubly chargedbinding orientation [28, 29]. (We should note that the
stereochemistry of the C-terminal Asp residue was not compounds 2 and 4 results in dramatically improved
in vitro antifungal activity (based on susceptibility ofconfirmed in these studies. We observe similar DNA
binding affinities and similar biological effects when Saccharomyces cerevisiae), with an MIC of 4 g/ml ob-
served for compound 2 and an MIC of 8–16 g/ml ob-compounds are made from D-Asp-resin and from L-Asp-
resin, which could indicate that the stereochemistry is served for compound 4 (Figure 1). Although the reasons
for this increase in activity are not yet clear, a likelynot important for the DNA binding, or that the resin
cleavage chemistry results in interconversion.) Given explanation is that addition of the second Dp moiety
improves the uptake properties of the compounds. Ifthe large differences in binding affinity and specificity
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was significantly less active against Aspergillus or other
filamentous fungi (data not shown). Although the cellular
basis for the different behavior in budding versus fila-
mentous fungi is not understood, this is a common feature
of antifungal therapies (e.g., flucytosine, fluconazole) and
is probably related to cellular uptake/permeability [30].
Compound 4 was also active against the same panel of
pathogens, but with decreased potency similar to that
seen with S. cerevisiae.
In Vivo Activity of Antifungal Hairpin Polyamides
We also tested compound 2 for in vivo efficacy in a
mouse model of acute fungal infection (Figure 2B). In
this study (see Experimental Procedures for details),
compound 2 or the positive control amphotericin B were
injected into mice shortly after i.v. administration of a
lethal dose (LD90–100) of Candida albicans. Efficacy is
measured by mouse protection over time. In this animal
model, compound 2 displayed significant efficacy in a
dose-dependent fashion. Thus, compound 2 has suffi-
cient potency, stability, and bioavailability to be active
in vivo. It should also be noted that acute rodent toxicity
testing at these same doses indicated that compound 2
is well tolerated (100% survival; no significant changes
in serum chemistry or behavior/appearance; data not
shown). Hairpin compound 2 showed excellent meta-
bolic stability in serum and in liver microsomes (data not
shown), indicating that the observed activity is resulting
from the intact hairpin, and not from a smaller metabo-
lite. Based on in vitro potency, in vivo activity, and lack
of acute toxicity, hairpin polyamides may have potential
as novel mechanism-of-action antifungal agents.
Dependence of Antifungal Activity on Genomic
DNA Content and DNA Recognition Site
To better understand the underlying mechanism behind
antifungal activity, we investigated the interaction be-
tween hairpin polyamides and yeast chromosomal DNA.
Figure 2. In Vitro and In Vivo Activities of Hairpin Polyamide 2, ImPy First, to verify that DNA was indeed the target through
PyPy--PyPyPyPy-Asp(Dp)-Dp which fungal cytotoxicity was mediated, we tested
(A) In vitro susceptibility testing (MIC). All strains were tested using whether increasing genomic DNA content could reduce
the broth microdultion plate method according to NCCLS guidelines susceptibility. It has been demonstrated previously that
(see Experimental Procedures).
increasing gene dosage of a drug target increases resis-(B) In vivo activity was measured in a murine acute fungemia model.
tance of Saccharomyces cerevisiae to the correspond-Groups of 10 mice were inoculated intravenously with 107 CFU Can-
ing drug by requiring higher effective concentrations todida albicans per mouse. Compound 2 or Amphotericin B were
administered intraperitoneally (IP) one hour after fungal inoculation. overcome target function [31, 32]. Thus, if the genome
Mortality was recorded once daily for 10 days. was the key target, either globally or a discrete subset,
increasing the dosage of the genome (by increasing the
complement of chromosomes or ploidy) should confer
increasing resistance to hairpin polyamides. The ratio-so, these results suggest that improved uptake can
overcome a reduction in DNA binding affinity. nale is that increases in ploidy should increase the cellu-
lar concentration of DNA target sites and, therefore,We tested doubly charged hairpin polyamides on sev-
eral clinically relevant fungal pathogens in order to fur- require higher intracellular concentrations of compound
to achieve critical occupancy at those sites.ther explore the spectrum of cytotoxicity. Figure 2A
shows the minimal inhibitory concentration (MIC) from Figure 3A shows growth on MIC-determination plates
for haploid (1n), diploid (2n), and tetraploid (4n) strainsin vitro susceptibility testing on several yeast-like patho-
gens (Candida albicans, Candida parapsilosis, Candida of Saccharomyces cerevisiae in the presence of com-
pound 2. MIC for these strains clearly increases in pro-tropicalis, Cryptococcus neoformans) as well as a fila-
mentous fungus (Aspergillus niger) for compound 2. In- portion to ploidy or genomic DNA content: 4 g/ml for
haploids, 8 g/ml for diploids, and 16 g/ml for tetra-terestingly, compound 2 is also active against a variety
of yeast-like pathogens with similar potencies as mea- ploids. In control experiments, a similar dependence on
ploidy is seen for other compounds that kill via chromo-sured against Saccharomyces cerevisiae. Compound 2
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Figure 3. Effects of Yeast Genomic Content (Ploidy) on Activity of a Series of Hairpin Polyamides with Increasing G,C Content in their Target
Sites
Susceptibility of S. cerervisiae strains to antifungal polyamides was measured by the broth microdilution assay exactly as in Figure 2. Haploid
(1n), Diploid (2n), and Tetraploid (4n) yeast were tested in duplicate.
(A) Optical density of a test plate showing growth in the presence of compound 2.
(B) Compound series with increasing Im substituents and, therefore, GC content in the binding site. Number of theoretical binding sites in
the Saccharomyces genome was obtained using the PatMatch search engine on the Saccharomyces Genome Database (SGD) web server
(http://genome-www.stanford.edu/Saccharomyces).
somal DNA binding, such as the alkylator methyl meth- 3B, increasing the number of Im/Py pairings decreases
potency against S. cerevisiae. Nevertheless, where ac-ane sulfonate (MMS), but not for compounds with an
enzymatic or other non-DNA target such as clotrimazole tivity is observed, it is dependent on chromosomal DNA
content with a doubling of the chromosome number(data not shown). Titration of the potency of compound 2
by genomic DNA suggests that chromosomes are the resulting in a 2-fold increase in MIC as in Figure 3A.
One explanation for the decreased potency of com-actual target and that antifungal activity is through a
DNA binding mechanism. pounds with increasing G,C target site content is high-
lighted in the last column of Figure 3B. The predictedTo assess the role of the recognition site programmed
into the polyamide, a series of compounds was synthe- binding site for each compound was scanned against
the Saccharomyces genome sequence (see figure leg-sized that recognize different target sites with increasing
G,C content relative to compound 2. As shown in Figure end), and the number of hits is indicated. 7-bp predicted
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binding sites were used for this search, based on known
end effects for hairpin polyamides [27]. There are pro-
gressively fewer target sites in the genome for com-
pounds that recognize sequences with increasing GC
content. Thus, whether compound binding causes more
global chromosome perturbations (e.g., interference
with chromosome topology [33]) or more discrete events
(e.g., interference with transcription of specific genes
[22]), the likelihood that a binding event(s) results in a
deleterious outcome increases with its frequency along
the chromosome. If binding events are roughly dictated
by the predicted match sequences shown in Figure 3B,
one would predict that each compound might have dif-
ferent aspects of mechanism, since the overall binding
patterns would be different.
A second possibility, however, is that there is a
defined set of key target sites which are better recog-
nized by hairpins that bind to sequences of the form
5-WWGWWWW-3 or to A,T-rich sequences in general.
In this case, overall binding patterns, and therefore
mechanism, might be the same, with potency simply
being a reflection of compound affinity for the target
sites. Still a third possibility is some combination of
sequence-driven and affinity-driven effects. As shown
below, this last possibility may most closely approxi-
mate the true mechanism.
DNA Damage-Sensitive Yeast Are Not
Hypersensitive to Compound 2 Figure 4. Susceptibility of S. cerevisiae Strains to Compound 2 or
Hairpin polyamides like compounds 1–8 reversibly bind Methyl-Methane-Sulfonate (MMS) Was Measured by the Broth Mi-
crodilution Assay as in Figure 2DNA in vitro [13, 14]. Since these compounds appear
Two DNA damage-sensitive mutants (rad9, mec1) and their con-to be acting via a DNA-based mechanism in vivo, we
genic wild-type strains (RAD9, MEC1) were tested. Optical densitieswished to verify that lethality was not a result of DNA
are from a test plate showing growth of in the presence of MMS ordamage or chromosome breakage. DNA damaging ac-
compound 2.
tivity might provide a toxicity hurdle for developing anti-
fungal therapeutics (although all acute animal toxicity
testing has shown excellent tolerability; see above).
breakage. In addition, the antifungal effects of com-
We tested compound 2 on S. cerevisiae mutant strains
pound 2 are probably not entirely mediated via global
that are hypersensitive to various perturbations of chro-
changes in chromosome structure such as topology/
mosomal integrity (Figure 4). RAD9 and MEC1 encode
supercoiling, replication, or segregation, since interfer-
genes whose products function in checkpoint pathways
ence with these processes would score positive in this
that monitor genomic integrity or incompletely repli-
assay [34–36]. Therefore, the primary mechanism by
cated DNA. These pathways negatively feed back on cell
which hairpin polyamides effect yeast cell death may
cycle progression so as to give the cell the opportunity to
be to interfere with the use of chromosomal DNA as a
repair any defects before catastrophic events occur at
template for gene transcription [22].
mitosis. In the absence of these functions, cells become
hypersensitive to agents that disrupt chromosomal in-
tegrity (e.g., 	/UV irradiation, radiomimetic drugs, Hy- Validation of the S. cerevisiae Hypersensitivity
Growth Assay to Identify Antifungaldroxyurea), since the cell no longer has the opportunity
for repair (reviewed in [34]). Compound Targets
If transcriptional interference is the primary activity ofThe top panel of Figure 4 shows that mutant strains
defective in either Rad9p or Mec1p function displayed antifungal polyamides, the question arises as to whether
interference is global across the genome or occurs atincreased sensitivity (decreased MIC) to the radiomimetic
drug methyl methane sulfonate (MMS). This increase is more specific sites of action. In a comprehensive hunt
for polyamide targets/sites-of-action, we employed aconsistent with previous results, which showed increased
sensitivity to MMS for rad9 mutants [35] as well as a genomic approach to assay all Saccharomyces essen-
tial genes for the potential of polyamide intervention.Mec1-dependent activation of the S phase checkpoint
and concomitant slowing of chromosomal DNA replica- The assay measures drug hypersensitivity in target-
compromised cells based on a previously reportedtion [36]. In contrast, no change in activity was seen be-
tween the mutant and wild-type strains for compound 2. method that has been successfully used to identify anti-
fungal drug targets [37]. Decreased gene dosage of aThis result suggests that compound 2 binds reversibly
and does not induce DNA damage or chromosome drug target from two copies to one copy in heterozygous
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Figure 5. Diploid Yeast Cells Heterozygous
for a Target Gene (ALG7) Display Greater
Sensitivity to Tunicamycin than Nontarget
Heterozygotes
Growth curves are for a single 96-well plate
that contains 94 representative yeast strains
heterozygous for different essential genes
plus 2 media blanks. The strains were chosen
at random, but to include the primary tuni-
camycin target gene ALG7. The upper graph
shows overlapping growth curves for all 94
strains in rich media in the absence of drug.
The lower graph shows growth in the pres-
ence of a sublethal dose of the test com-
pound tunicamycin (1.5 M).
yeast strains results in increased sensitivity to that cog- Differential Sensitivity of Yeast Heterozygotes
to a Pair of Antifungal Polyamides with Differentnate drug. In the heterozygous cell, the target becomes
more rate-limiting for growth in the presence of a suble- Sequence Specificity
A panel of 743 Saccharomyces essential gene heterozy-thal concentration of drug due to the reduction in copy
number by 50%. gotes was assayed for hypersensitivity as in Figure 5 in
the presence of tunicamycin, compound 2, and com-We modified the assay format to assess drug hyper-
sensitivity by scoring growth rates in 96-well plates (see pound 5. This collection represents approximately 75%
of all yeast essential genes. Growth rates were mea-Experimental Procedures for details). A plate assay en-
abled us to scan all essential gene heterozygotes in sured and only those strains that scored as hypersensi-
tive are plotted in Figure 6. Growth defects of the af-parallel by simply measuring turbidity over time. To vali-
date the assay, we first performed a feasibility study fected strains were semiquantitatively assigned as mild,
moderate, or severe (see Experimental Procedures forusing a well-characterized antifungal compound, tuni-
camycin. Tunicamycin specifically targets Asn-linked details).
As shown in Figure 6, there was one heterozygoteglycosylation, thus preventing proper modification of
secreted proteins [38, 39]. Figure 5 shows the results strain (PRS1) that showed increased sensitivity to all
compounds, indicating nonspecific effects due to thefrom a prototypical 96-well plate carrying 94 different
Saccharomyces essential gene heterozygotes. Strains overall poor health of cells with decreased PRS1 func-
tion. Only the PRS1 strain in the collection displayedwere inoculated from stationary phase at t  0. The
upper graph shows overlapping growth curves for all such nonspecific behavior.
Tunicamycin affected 8 strains uniquely: the target94 strains in rich media in the absence of drug. The
lower graph shows growth in the presence of a sublethal ALG7 as well as other mutations in the secretory path-
way (CDC24, PBN1) [40–42]. This observation highlightsdose of the test compound tunicamycin (1.5 M). Note
that growth is slowed for all strains due to the effects the point that this approach may also identify other rate-
limiting steps in the target pathway. In addition, thereof intermediate tunicamycin treatment. The strain het-
erozygous for the tunicamycin target (alg7/ALG7) dis- were 5 strains not obviously involved in N-linked glyco-
sylation or secretion (PTA1, TIF11, SRB6, CBF2, RPC10).plays significantly slower growth and greater sensitivity
due to combined effect of intermediate tunicamycin Although it is not yet clear why deficiencies in these
functions lead to tunicamycin hypersensitivity, they maytreatment and the lower copy number of ALG7. These
results are consistent with previous studies [37–39] represent downstream or secondary effects from de-
fects in glycosylation or secretion (see also [37]).identifying the ALG7 locus as a tunicamycin target.
Based on tunicamycin as a validative example, putative To summarize the hairpin polyamide results, outside
of PRS1, a total of 15 strains displayed hypersensitivityantifungal targets can be identified by determining
which heterozygous loci show this drug-induced hyper- to compound 5 (5-WWGGWWW-3 target site) and 17
strains hypersensitivity to compound 2 (5-WWGWWWW-sensitivity [37].
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Figure 6. A Panel of S. cerevisiae Essential
Gene Heterozygotes was Screened as in Fig-
ure 5 Against Tunicamycin, Compound 2, and
Compound 5
743 strains were tested in duplicate at multi-
ple sublethal concentrations of each com-
pound; thus, the x axis contains 743 catego-
ries for each heterozygote strain in the
collection. Hypersensitive strains were as-
sessed as having mild, moderate, or severe
growth defects (see Experimental Proce-
dures), and only those are indicated.
3 target site). Out of these, there were 6 strains hit by Although we do not yet have a full explanation for
these observations and the molecular basis of specific-both compounds 2 and 5 (RPL33A, GFA1, MCD4, ARP4,
RPL30, TAH18); Compound 5 affected 9 strains uniquely, ity, many of the findings we report here are in good
agreement with a previous report studying hairpin poly-while Compound 2 targeted 11 strains uniquely.
Thus, it appears that only a relatively small number amide:DNA interactions in mammalian cells [43]. Using
microarray analysis to determine polyamide effects onof essential gene functions are sensitive to both com-
pounds 2 and 5. If binding events that produced a func- mRNA expression, these authors concluded that al-
though putative match binding sites are found widely intional outcome were widespread across the genome,
one might expect a more global response in this type the genome, only a relatively small number of genes
were targeted transcriptionally in the cell. In addition,of assay. Instead, the profile of sensitized strains indi-
cates a level of specificity that approximates tuni- there did not seem to be a common theme regarding
matched polyamide target sites with respect to cluster-camycin, an agent with a specific cellular target. The
nature of such specificity is not currently known. For ing, positioning, or flanking sequence context in the
promoters of these affected genes (although affectedexample, only a subset of putative genomic binding sites
may be occupied at growth inhibitory concentrations, gene promoters did contain matched binding sites). In
fact, the specific gene that was the intended target ofor only a subset of binding events may affect a biological
outcome. the designed polyamides was unaffected. The authors
also noted that small changes in polyamide structureLooking at the gene functions affected by antifungal
polyamides reveals no obvious biological theme. One led to differences in transcriptional effects similar to
what we see in the yeast heterozygote screening (Figurewould not necessarily expect one, however, if com-
pounds act via DNA binding. The only common feature 6). Finally, polyamide treatment did not induce DNA
damage reporters, but rather downregulated them, indi-necessary would be binding site attributes such as se-
quence and position, not function. We have done some cating the absence of measurable DNA damage, which
is again consistent with our finding that DNA damage-preliminary sequence analysis at the affected loci (site
frequency, positioning, clustering), but have not seen sensitive yeast mutants are not hypersensitive to these
compounds (Figure 4).any striking common features. Clearly, more work is
needed to elucidate compound behavior in vivo and These findings indicate that we do not yet fully under-
stand the rules for predicting genomic effects of polyam-molecular mechanisms of action.
Both compounds share a common response pattern ide treatment based on rational design. A genomic ap-
proach to this problem should be informative inindicating similar aspects of mechanism, as well as tar-
gets unique to each compound. The similar responses conjunction with studies elucidating biochemical and
biophysical parameters of these compounds. In this re-could be a reflection of key target sites recognized by
both compounds, though perhaps with unequal affini- gard, Saccharomyces cerevisiae is an ideal organism in
which to learn more about polyamide behavior at theties, since compound 2 is more potent than compound 5.
The unique responses could be a reflection of altered cellular level. We have already established rules to
achieve cell penetration and nuclear activity. Further-sequence specificity that programs a different set of
discrete events. These data suggest some degree of more, S. cerevisiae is an excellent eukaryotic cell model
with a small, well-characterized genome and a multitudespecificity with respect to gene inactivation.
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electrospray mass spectroscopy (LCQ Finnigan mass spectrometer)of genetic and genomic tools to call upon. As shown
and were lyophilized to an off-white powder. NMR determinationshere, we have begun to employ this approach for poly-
were made on a Varian 400 MHz spectrometer.amides within the antifungal arena, but these studies
Compound 2 ImPyPyPy--PyPyPyPy-Asp(Dp)-Dp
should be enlightening in a broader context. 1H NMR (d6-DMSO) 
 10.46 (s, 1H); 9.97 (s, 1H); 9.94 (s, 1H); 9.93 (s,
1H); 9.92 (s, 1H); 9.91 (s, 1H); 9.85 (s, 1H); 8.06-8.09 (m, 2H); 7.94-
7.96 (m, 2H); 7.39 (s, 1H); 7.29 (s, 1H); 7.24 (bs, 3H); 7.21 (s, 1H);Significance
7.18 (bs, 3H); 7.07 (bs, 3H); 7.04 (s, 1H); 6.98 (s, 1H); 6.91 (s, 1H);
6.89 (s, 1H); 4.59-4.64 (m, 1H); 4.00 (s, 3H); 3.85 (bs, 12H); 3.84 (s,Eight-ring hairpin polyamides containing N-methylimid-
3H); 3.81 (bs, 6H); 3.21-3.25 (m, 2H); 3.05-3.10 (m, 4H); 2.55-2.57 (m,
azole (Im) and N-methylpyrrole (Py) amino acids have 2H); 2.34-2.37 (m, 2H); 2.27-2.30 (m, 4H); 2.20 (m, 12H); 1.91 (s, 3H);
been shown to bind with subnanomolar affinity to dis- 1.78-1.80 (m, 2H); 1.53-1.58 (m, 4H). MS calc. 1348.9, exp. 1348.7.
Compound 4 ImPyPyPy--ImPyPyPy-Asp(Dp)-Dpcrete DNA sites and to modulate a variety of DNA-
1H NMR (d6-DMSO) 
 10.46 (s, 1H); 10.27 (s, 1H); 9.99 (s, 1H); 9.96dependent biological processes. We show here that ad-
(s, 1H); 9.95 (s, 1H); 9.93 (s, 1H); 9.91 (s, 1H); 8.04-8.09 (m, 2H); 7.90-dition of a second positive charge at the C terminus of
7.95 (m, 2H); 7.47 (s, 1H); 7.39 (s, 1H); 7.29 (s, 1H); 7.27 (s, 1H); 7.24an 8-ring hairpin polyamide confers activity against a
(bs, 2H); 7.22 (s, 1H); 7.18 (bs, 3H); 7.15 (s, 1H); 7.07 (s, 1H); 7.04 (s,
number of clinically relevant fungal strains in vitro, and 1H); 6.97 (s, 1H); 6.90 (s, 1H); 4.59-4.64 (s, 1H); 4.00 (s, 3H); 3.96 (s,
activity against Candida albicans in a mouse model. 3H); 3.85 (bs, 12H); 3.80 (bs, 6H); 3.20-3.23 (m, 2H); 3.06-3.09 (m,
4H); 2.53-2.55 (m, 2H); 2.35-2.37 (m, 2H); 2.20-2.26 (m, 4H); 2.12 (m,Antifungal activity is modulated by the ploidy of the
12H); 1.91 (s, 3H); 1.77-1.80 (m, 2H); 1.51-1.53 (m, 4H). MS calc.yeast, with increasing genome copy numbers (cellular
1349.8, exp. 1349.7.DNA content) leading to a corresponding reduction in
Compound 5 ImImPyPy--PyPyPyPy-Asp(Dp)-Dphairpin antifungal activity. Increasing G,C content within 1H NMR (d6-DMSO) 
 10.36 (s, 1H); 9.96 (s, 1H); 9.34 (bs, 2H); 9.92
the hairpin target site decreases antifungal activity in a (s, 1H); 9.85 (s, 1H); 9.74 (s, 1H); 8.04-8.07 (m, 2H); 7.92-7.96 (m,
manner proportional to the predicted number of hairpin 1H); 7.85-7.90 (m, 1H); 7.58 (s, 1H); 7.46 (s, 1H); 7.29 (s, 1H); 7.24
(bs, 2H); 7.23 (s, 1H); 7.18 (bs, 2H); 7.15 (s, 1H); 7.08 (s, 1H); 7.06 (bs,binding sites in the Saccharomyces genome. DNA dam-
2H); 6.96 (s, 1H); 6.91 (s, 1H); 6.89 (s, 1H); 4.59-4.62 (s, 1H); 4.01 (bs,age-sensitive yeast strains show no increase in sensitiv-
6H); 3.85 (bs, 6H); 3.84 (s, 3H); 3.81 (s, 3H); 3.80 (bs, 6H); 3.23-3.17ity to the hairpin polyamides, indicating that the critical
(m, 2H); 3.03-3.09 (m, 4H); 2.52-2.55 (m, 2H); 2.27-2.31 (m, 2H); 2.15-DNA binding events are reversible. Even though the
2.20 (m, 4H); 2.07 (s, 6H); 2.06 (s, 6H); 1.90 (s, 3H); 1.78-1.82 (m, 2H);
compounds in this study are predicted to bind to many 1.47-1.53 (m, 4H).
sites within the yeast genome, experiments performed Compound 7 ImImPyPy--ImPyPyPy-Asp(Dp)-Dp
1H NMR (d6-DMSO) 
 10.36 (s, 1H); 10.27 (s, 1H); 9.99 (s, 1H); 9.96with a panel of heterozygote mutant yeast strains in-
(s, 1H); 9.94 (bs, 2H); 9.73 (s, 1H); 8.04-8.07 (m, 2H); 7.89-7.94 (m,dicate that a discrete number of genes/gene functions
2H); 7.57 (s, 1H); 7.46 (bs, 2H); 7.28 (bs, 2H); 7.24 (s, 1H); 7.23 (s,are affected by the compounds. This indicates that the
1H); 7.18 (s, 1H); 7.15 (bs, 2H); 7.07 (bs, 2H); 6.96 (s, 1H); 6.90 (s,antifungal activity may result from interference with only
1H); 4.59-4.64 (s, 1H); 4.01 (bs, 6H); 3.96 (s, 3H); 3.85 (bs, 9H); 3.80
a limited subset of genes. These results taken together (bs, 6H); 3.18-3.20 (m, 2H); 3.05-3.08 (m, 4H); 2.53-2.56 (m, 2H); 2.35-
indicate a potential DNA binding mechanism-of-action 2.36 (m, 2H); 2.16-2.20 (m, 4H); 2.07 (m, 12H); 1.90 (s, 3H); 1.78-1.82
(m, 2H); 1.48-1.51 (m, 4H). MS calc. 1350.6, exp. 1350.7.for the observed antifungal activity, demonstrating that
these compounds may have potential as novel mecha-
Biochemistrynism-of-action antifungal agents. Overall, we have de-
DNase I footprinting was performed according to published proto-veloped general chemical principals for conferring anti-
cols [44].
fungal activity on hairpin polyamides, which should
encourage the further use of yeast systems for under- Fungal Strains
standing polyamide behavior at the cellular level. All Candida (C. albicans, C. tropicalis, C. parapsilosis), Cryptococcus
(C. neoformans), and Aspergillus (A. niger) strains were from the
American Type Culture Collection (ATCC). Strain numbers are indi-Experimental Procedures
cated in Figure 2. Saccharomyces cerevisiae strains used in ploidy
experiments were either from Research Genetics (BY4741, MATaReagents and Media
haploid; BY4743, MATa/ diploid) or ATCC (#204714, MATa/a//Boc--alanine PAM resin (substitution 1.1 mmol/gram) was pur-
alpha tetraploid). DNA damage hypersensitive yeast mutants werechased from Peptides International. Boc-D-Asp(OBzl)-PAM resin
either rad9::HIS3 (“rad9”) or mec1::TRP1 sml1::HIS3 (“mec1”) [45](substitution 0.5 mmol/gram) was purchased from NovaBiochem.
in the W303 MATa background. Congenic control strains for DNAImidazole-2-carboxylic acid, Boc-4-aminoimidazole-2-carboxylic
damage assessment were RAD9 W303a (“RAD9”) or MEC1 sml1::acid, and Boc-4-aminopyrrole-2-carboxylate OBt ester were pur-
HIS3 W303a (“MEC1”). The collection of S. cerevisiae diploid strainschased from Oakwood Products, Inc. RPMI-1640 growth media,
heterozygous for essential genes was purchased prearrayed in 96-methyl-methane sulfonate (MMS), tunicamycin, and clotrimazole
well plates from Research Genetics.were purchased from Sigma. Potato dextrose agar was purchased
from Remel. YPD media is 1% yeast extract (Difco), 2% peptone
(Difco), 2% dextrose (Sigma). In Vitro Susceptibility Testing
In vitro susceptibility testing (MIC) was conducted by the NCCLS
broth microdilution assay in 96-well plates [46, 47]. SaccharomycesChemistry
cerevisiae was pregrown on YPD agar plates and tested in YPDCompounds were synthesized stepwise by established solid phase
media at 30C. All other strains were pregrown on potato dextrosemethods from either Boc--alanine PAM resin or Boc-D-Asp(OBzl)-PAM
agar plates tested in RPMI-1640 media at 37C.resin [25]. Aminolysis (including substitution of the -carboxybenzyl
ester with Dp) was performed with neat dimethylaminopropylamine
(Dp) (2 ml for 0.5 gram resin) at 60C for 12 hr. The resulting solution Acute Fungemia Mouse Model
Compound efficacy in a mouse model of acute fungemia was testedwas purified by reverse HPLC using a Hamilton PRP-1 divinylben-
zene 250  50 mm column with a gradient elution (buffer A: 0.5% by MDS Pharma Services (Taiwan) using protocol #609010. Groups
of 10 ICR derived male mice weighing 22  1 grams were used.aqueous acetic acid, buffer B: acetonitrile; 0%–60% B over 120
min at a flow rate 20 ml/min). Correct fractions were identified by Mice were inoculated intravenously (IV) with 107 CFU/0.2 ml/mouse
Antifungal DNA Binding Hairpin Polyamides
643
(LD90–100) of Candida albicans (ATCC 10231) suspended in phos- 10. Dyatkina, N.B., Roberts, C.D., Keicher, J.D., Dai, Y., Nadherny,
J.P., Zhang, W., Schmitz, U., Kongpachith, A., Fung, K., Novikov,phate-buffered saline (pH 7.4) without mucin. Test compounds (vehi-
cle 0.9% NaCl) were administered intraperitoneally (IP) one hour A.A., et al. (2002). Minor groove DNA binders as antimicrobial
agents. 1. Pyrrole tetraamides are potent antibacterials againstafter the fungal inoculation. Amphotericin B (10 mg/kg) was the
reference standard. Mortality was recorded once daily for 10 days. vancomycin resistant Enterococci and methicillin resistant
Staphylococcus aureus. J. Med. Chem 45, 805–817.
11. Lou, L., Velligan, M., Roberts, C., Stevens, D.A., and Clemons,Yeast Heterozygote Hypersensitivity Screen
K.V. (2002). DNA binding compounds targeting fungal patho-The collection of diploid Saccharomyces cerevisiae strains hetero-
gens: an emerging concept in the discovery of novel antifungalzygous for essential genes was purchased from Research Genetics
agents. Curr. Opin. Investig. Drugs 10, 1437–1445.(release A) as frozen stocks prearrayed on 9 96-well plates. For the
12. Lombardi, P., and Crisanti, A. (1997). Antimalarial activity ofgrowth hypersensitivity assays, 2 l of thawed glycerol stocks were
synthetic analogues of distamycin. Pharmacol. Ther. 76,first inoculated into fresh 96-well plates containing 98 l YPD  100
125–133.g/ml G418 per well and incubated at 30C for 48 hr to obtain
13. Dervan, P.B. (2001). Molecular recognition of DNA by small mol-saturated cultures of each strain. Resuspended plates were then
ecules. Bioorg. Med. Chem. 9, 2215–2235.diluted 1:10 (10 l to 90 l) into a fresh 96-well plate. This 1:10
14. Reddy, B.S., Sharma, S.K., and Lown, J.W. (2001). Recent devel-dilution was then used as source plate for further dilution (1:5) into
opments in sequence selective minor groove DNA effectors.daughter plates, which contained either tunicamycin (positive con-
Curr. Med. Chem. 5, 475–508.trol) or the polyamide of interest at four different (sub-MIC) concen-
15. Pelton, J.G., and Wemmer, D.E. (1989). Structural characteriza-trations. Growth curves were monitored using a system with a Tecan
tion of a 2:1 distamycin A.d(CGCAAATTGGC) complex by two-Twister robotic arm integrated with a Tecan Sunrise plate reader in
dimensional NMR. Proc. Natl. Acad. Sci. USA 15, 5723–5727.a 30C warm room. Absorbance (A600) was measured every 90 min
16. Mrksich, M.M., Parks, M.E., and Dervan, P.B. (1994). Hairpinfor 24 hr. Data was parsed and appropriately formatted into MS
peptide motif. A new class of oligopeptides for sequence-spe-Excel files using Magellan software. Growth curves were fit using
cific recognition in the minor groove of double-helical DNA. J.a Boltzman function with initial OD, final OD, slope at midpoint,
Am. Chem. Soc. 116, 7983–7988.and time at midpoint as the four parameters used for fitting. As a
17. White, S., Szewczyk, J.W., Turner, J.M., Baird, E.E., and Dervan,semiquantitative measure of hypersensitivity, strains which showed
P.B. (1998). Recognition of the four Watson-Crick base pairs ingrowth rates (slope at midpoint) 50%–75% of control (plate average)
the DNA minor groove by synthetic ligands. Nature 391,were scored as having a mild growth defect; 25–50% of control, a
468–471.moderate growth defect; 25%, a severe defect.
18. Kielkopf, C.L., White, S., Sewczyk, J.W., Turner, J.M., Baird,
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